18 /100
LOW RISK
Score updated May 29, 2026

MREO — Mereo BioPharma Group plc Dilution Risk Tracker

Track MREO dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track MREO — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
20
💰 Cash Runway
10
📊 Float Risk
40
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

🌥️
Advisory
Moderate dilution signals present
27%
🔄 Reverse Split 55%
• 50-day avg $0.30 below $1 exchange minimum
🔔 Track MREO — Get forecast alerts →

💹 Market Data

Market Cap$55.07M
Shares Outstanding159.62M
FloatN/A
Cash$36.22M
DebtN/A
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↓ 34.3% shares (2025Q4 vs prior)
76 institutional holders · 67.92M shares
#1 Rubric Capital Management LP 15.31M shares
#2 683 Capital Management, LLC 15.03M shares
#3 EcoR1 Capital, LLC 7.86M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest6.51M
Days to Cover4.4
% of FloatN/A
FINRA data as of Apr 30, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Dec 31, 2025
xbrl XBRL CONVERTIBLE Dec 31, 2024
Full SEC filing analysis available with free account

📰 Recent News

No recent news
Track MREO Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking MREO — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
🔬 More Research for MREO
📊 MREO FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 MREO Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.